CLINICAL LABORATORY POINT OF CARE TESTING

Medical Director: Josh Bornhorst, Ph.D. (501-603-1260, pager 501-405-8157)
Point of Care Coordinator: Bonnie Wood BSMT (ASCP) (501-686-7044, pager 501-688-6489)

The Clinical Laboratory Point of Care Testing encompasses the technical oversight of all the waived testing procedures performed by ancillary testing sites in the ER, OR, OPC, ACRC, and all clinics and nursing stations at UAMS.

TEST	COLLECTION/ CONTAINER	NORMAL RANGE	CRITICAL VALUE
Coloscreen	Stool Specimen	Negative	N/A
Gastroccult	Gastric Contents	Negative	N/A
Urine Preg. Test	Fresh Urine	Negative	N/A
H. pylori CLO test	Gastric mucosal biopsy	Negative	N/A
Nitrazene pH	Gastric or Vaginal Fluid	See Procedure	N/A
Bladder Tumor Antigen	Fresh Urine	Negative	N/A
Precision PCX Glucose	Capillary Blood	70-105 mg/dl	<60 or >400 mg/dl
Hemocue B HgB	Whole Blood	11.5-17.5 g/dl	<7.0 or >18.0 g/dl
Hemocue Glucose	Whole Blood	70-105 mg/dl	<60 or > 400mg/dl
Group A Strep	Throat Swab	Negative	N/A
Dipstick Urine	Fresh Urine	pH 5-8 SG 1.003-1.030 Urobili. <1 EU/dl All other urine parameters should be Negative	3+ Glucose 3+ Ketone

Moderately complex tests accredited by the CAP and monitored by the clinical laboratory include:

TEST	CONTAINER	NORMAL VALUE	CRITICAL VALUE
I-STAT	Lithium Heparin	NA: 135-145 mEq/L K: 3.5-5.0 mEq/L CL: 95-105 mEq/L CO₂: 22-31 mEq/L Gluc: 70-105 mg/dl HCT: 34-50 % BUN: 6-20 mg/dl Creatinine: 0.5-1.1 mg/dL Troponin I: < 0.1 ng/mL = Negative 0.1-0.6 ng/mL = Indeterminate > 0.6 ng/mL = Positive ACT: 79-149	NA: <120 or >160 mEq/L K: < 3.0 or > 5.5 mEq/L CL: < 80 or > 120 mEq/L CO₂: <10 or > 40 mEq/L Gluc: <50 or > 450 mg/dl HCT: < 21 or > 55 % Troponin I: > 0.6 ng/mL
Activated Clotting Time	ACT tube	See Procedure	> 400 secs.
PT	Whole Blood	PT: 10.9-16.6 INR: 0.9-1.3	INR > 5

Requests for new waived or point of care tests at any new UAMS site must be submitted to the Point of Care Coordinator using the attached Request for Point of Care Testing form and Business Manager's Financial Form. The completed forms must be authorized by the physician requesting the testing. The Laboratory Medical Director or Physician designee consults and reviews the request, makes recommendations and presents it to Hospital Administration for their review. (See Attachments A & B)